Bioengineered Protein Drug Market Players:
- Abbott Services
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson Services, Inc.
- Amgen Inc.
- Bayer AG
- Dr. Reddy’s Laboratories Ltd.
- Biocon Limited
- Eli Lilly and Company
- Sanofi S.A
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of bioengineered protein drug is estimated at USD 438.49 billion.
The global bioengineered protein drug market size was over USD 412.15 billion in 2025 and is anticipated to witness a CAGR of around 7.1%, crossing USD 818.37 billion revenue by 2035.
Asia Pacific bioengineered protein drug market holds the largest share by 2035, driven by chronic disease cases and the aging population.
Key players in the market include Abbott Services, Johnson & Johnson Services, Inc., Amgen Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., Biocon Limited, Eli Lilly and Company, Sanofi S.A, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd.
